Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

TENKU

TenX Keane Acquisition (TENKU)

TenX Keane Acquisition
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TENKU
일자시간출처헤드라인심볼기업
2024/05/2204:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
2024/05/2106:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
2024/05/1605:24Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TENKUTenX Keane Acquisition
2024/01/3107:25Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TENKUTenX Keane Acquisition
2024/01/1906:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
2024/01/1106:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
2024/01/1105:21Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TENKUTenX Keane Acquisition
2024/01/1104:29GlobeNewswire Inc.TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment ProposalNASDAQ:TENKUTenX Keane Acquisition
2024/01/0906:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TENKUTenX Keane Acquisition
2023/12/2902:39Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TENKUTenX Keane Acquisition
2023/11/2107:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
2023/10/2420:42Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TENKUTenX Keane Acquisition
2023/10/2420:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
2023/10/2420:30PR Newswire (US)Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKUTenX Keane Acquisition
2023/10/2420:30GlobeNewswire Inc.Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.NASDAQ:TENKUTenX Keane Acquisition
2023/10/1906:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
2023/10/1905:00GlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKUTenX Keane Acquisition
2023/08/1703:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENKUTenX Keane Acquisition
2023/07/1905:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENKUTenX Keane Acquisition
2023/07/1905:00GlobeNewswire Inc.TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationNASDAQ:TENKUTenX Keane Acquisition
2023/05/1605:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TENKUTenX Keane Acquisition
2023/04/0105:33Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TENKUTenX Keane Acquisition
2023/02/1505:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
2023/02/1106:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TENKUTenX Keane Acquisition
2023/02/0822:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
2023/02/0820:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TENKUTenX Keane Acquisition
2022/12/0707:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TENKUTenX Keane Acquisition
2022/12/0706:58GlobeNewswire Inc.TenX Keane Acquisition Announces the Separate Trading of its Ordinary Shares and Rights Commencing on December 8, 2022NASDAQ:TENKUTenX Keane Acquisition
2022/10/2506:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TENKUTenX Keane Acquisition
2022/10/1903:20GlobeNewswire Inc.TenX Keane Acquisition Announces Closing of $66 Million Initial Public Offering, Including Partial Exercise of Underwriter’s Over-Allotment OptionNASDAQ:TENKUTenX Keane Acquisition
 검색 관련기사 보기:NASDAQ:TENKU